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Abstract 
 Chronically persistent bacterial infections are an enormous health problem and are 
prevalent in many medical settings. Often, the bacteria that cause these infections exhibit a 
small colony phenotype, grow slowly, produce biofilms and are resistant to antibiotics. In this 
study, I used Providencia rettgeri, an opportunistic human pathogen and a natural pathogen of 
Drosophila melanogaster. From previous research in the Lazzaro Lab, it was found that 
Providencia rettgeri also has a small colony variant (S strain) phenotype. Therefore, I 
hypothesized that our isolated S strain is a canonical small colony variant with an ability to 
persist in the host, Drosophila melanogaster. After conducting various experiments to 
determine the growth dynamics, biofilm capabilities and antibiotic resistance of the Providencia 
rettgeri S strain, I concluded that the S strain (small colony phenotype) of Providencia rettgeri is 
most likely not a suitable model strain for studying small colony variants and their implication in 
persistent infections. This is because although the S strain did exhibit slower growth and 
diminished host lethality compared to the wildtype strain (L strain), its ability to produce 
biofilms and its antibiotic resistance were either equal to or worse than the L strain. Although 
this strain may not be a canonical small colony variant, it’s slow growth and ability to persist in 
the host represents an interesting physiology worthy of continued study. A rescue experiment 
is currently in the works to determine if an identified mutation in the penicillin binding protein 
gene in the S strain is responsible for the small colony/low host lethality phenotype. The 
wildtype version of this gene, which is involved in cell wall synthesis and where the gene 
product is a known target for antibiotics, is hypothesized to restore the large colony size and 
advanced growth demonstrated by the wildtype strain when expressed in the mutant (S) 
background. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Introduction 
 Chronically persistent bacterial infections are an enormous problem for public health and can 
be impervious to treatment. Persistent infections tend to be prevalent in medical settings, 
especially with medical implantations such as pacemakers or urinary catheters and chronic 
health conditions such as cystic fibrosis (Tümmler, Weißbrodt, Rohde, Häußler, & Steinmetz, 
1999). Nevertheless, the study of chronic infections in vivo is currently difficult due to the fact 
that there is a lack of inexpensive and easily monitored animal infection systems. The 
bacterium that will be used in this study, Providencia rettgeri, is an opportunistic human 
pathogen that was also discovered to be a natural pathogen of Drosophila melanogaster, the 
model host for this study (Galac and Lazzaro 2011). Drosophila flies present a desirable model 
for infection studies due to their genetic tractability, ease of handling, and homology to 
mammalian innate immunity (Lemaitre and Hoffmann 2007). Previous research in the Lazzaro 
lab has shown that P. rettgeri is able to exhibit a bimodal infection in Drosophila melanogaster 
(where a percentage of flies are killed while the remaining flies survive with a chronic infection), 
offering a promising host-pathogen dynamic for studying persistent infections (Duneau 2017). A 
small colony variant (S strain) of Providencia rettgeri was identified by a collaborating lab (Justin 
Buchanan and Kristi Montooth, University of Nebraska-Lincoln) after isolation from an in vivo 
infection in Drosophila melanogaster.  
                                     
Figure 1- Colony morphology for both the wildtype (L strain) of Providencia rettgeri and the small colony variant (S 
strain) of Providencia rettgeri.     
       
The mutant arose in the gut of a larval fly that had been fed with Providencia rettgeri. Similar to 
the wildtype (L, large colony) strain, the small colony variant is able to persist in the fly, 
although it does so with a lower bacterial burden (103 CFU/fly vs 105 CFU/fly for L strain) and 
kills fewer host flies upon reinfection (10-20% lethality vs. 50-60% lethality elicited L strain).  
 
Figure 2- Bimodal infection kinetics of L and S strains measuring bacterial burden (left y-axis, black) and fly survival 
(right y-axis, gray) during infection of D. melanogaster. Solid lines represent pathogen burden (left y-axis) and dotted 
L 
(WT) S 
lines represent fly survival (right y-axis). Blue, L strain: Thick blue line represents L strain chronic infection burden, 
lighter blue line represents L strain lethal infection burden and blue dotted line represents survival of flies when 
infected with L strain. Orange, S strain: Thick orange line represents S strain chronic infection burden, lighter orange 
line represents S strain lethal infection burden and orange dotted line represents survival of flies when infected with 
S strain.  
 
Since small colony variants are often implicated in persistent infections, I was interested to 
determine if this S strain has any effect on persistent infections in Drosophila melanogaster. 
Canonical small colony variants have many common unique features including slow growth, 
ability to form biofilms and increased antibiotic resistance, which are all factors that could be 
implicated in the potential for the S strain to maintain a persistent infection (Santos and 
Hirshfield 2016). Given the preliminary data supporting its retention of persistence in the host, I 
hypothesized that our isolated S strain is a canonical small colony variant with an ability to 
persist in the host, Drosophila melanogaster.  
 
Methods: 
In vitro growth curves of S and L strains  
In vitro growth curves were performed in 96-well plates by measuring optical density 
(OD with absorbance wavelength of 600) over 24 hours using a SpectraMax 384 Plus (Molecular 
Devices) plate-reader. To initiate the growth curve, I inoculated 2 µL of an overnight culture of S 
or L into 198 µL of LB in wells of a clear flat-bottom 96-well plate (Globe Scientifics), resulting in 
a starting concentration of ~2x107 cells/well. A subset of wells was used as a control with only 
LB. I incubated the plate at 37°C with intermittent shaking for 24 hours. I acquired OD 
measurements every 15 minutes and plotted it as OD vs. time. 
 I also performed additional in vitro growth curves by culturing S and L strains in 
Erlenmeyer flasks containing LB. This approach allowed for samples to be extracted for both OD 
readings and viable counts (CFU/mL). I started flask cultures by transferring 1 mL of OD 1.7 S or 
L to a 500 mL flask containing 100 mL LB, resulting in a starting concentration of ~ 1x107 
cell/mL. Cultures were incubated at 37°C, 200 rpm for 8 hours. At each hour interval, I removed 
400 µL from each flask used to measure OD while I removed another 100 µL and plated onto LB 
agar for viable counts using a spiral plater (Don Whitely Scientific). 
 
In vivo growth curves of S and L strains  
 I performed In vivo growth curves of the S and L strains by independently infecting flies 
with each strain and plating bacterial cells of infected flies over the course of infection. I 
counted the resulting colonies to determine bacterial load (colony forming units (CFU)/fly). The 
experiments were performed in duplicate in both wildtype Canton S D. melanogaster, as well as 
in Relish mutant flies, which have a severely diminished immune response (Ertürk-Hasdemir 
2009). I infected Relish mutant flies and wildtype Canton S D. melanogaster flies with PBS (as a 
control), S strain or L strain (OD1 in PBS) using a pinprick infection (Khalil 2015) resulting in an 
initial administration of ~103 cells per fly. Fly survival was recorded over 72 hours by visual 
inspection. I measured bacterial load (CFU/fly) at 0, 4, 8, 24, and 48 hours by depositing single 
flies (10 per time point) into microfuge tubes containing 500 µL PBS and a 2.3 mm chrome steel 
bead (Biospec Products), homogenizing for 2 minutes (Talboys high throughput homogenizer), 
and plating onto LB agar with spiral plater (Don Whitely Scientific). Bacterial growth was plotted 
as CFU/fly vs. time, which was calculated by taking the estimated CFU/mL value and multiplying 
it by 0.5 to adjust for the PBS volume that contained a single homogenized fly.  
 To determine whether a higher concentration of S would facilitate a more L-like 
infection (more lethality and higher bacterial burden in chronic phase), I performed in vivo 
infections with the S strain at increasing ODs (1, 2, 5 and 10) and monitored fly survival over 1 
week. Fly survival from S strain infections were compared to infections with the L strain at OD1 
(control) and flies infected with sterile PBS (control). I examined bacterial load immediately 
upon infection (T0 ) to verify that infecting with increasing concentrations of S resulted in 
increasing bacterial load in the fly. I performed an additional experiment assessing bacterial 
load during the chronic phase (48 and 72 hours post infection) to determine if the higher doses 
of S increased fly lethality and bacterial load. For statistical analysis, I performed a Welch’s two-
sample t-test (unequal variance) for the in vivo infections in both Canton S D. melanogaster flies 
and relish mutant D. melanogaster flies. I also performed t-tests between the S and L strains to 
determine statistical significance between S and L bacterial load at 0, 4, 8, 24 and 48 hour 
marks post-infection (8-hour mark was excluded from relish mutant experiment). These were 
adjusted for a multiple-test correction. For the concentrated S infection experiment, I 
performed t-tests to determine statistical significance in bacterial load differences among 
different concentrations of S.  
 
In vitro biofilm assay 
 To determine the relative capability of the S and L strain strains to form biofilms, I used 
a staining method to quantify the biofilm size of each strain. I performed the assay according to 
O’Toole 2011 (O’Toole 2011). Briefly, 1:100 dilutions of overnight S and L cultures were used to 
seed a 96-well plate that was then incubated at 37°C for ~24 hours. I washed wells twice by 
submerging that plate in water and stained attached cells by adding 125 µL of 0.1% crystal 
violet and incubating for 15 minutes at room temperature. I washed the plate again three times 
and dried before solubilizing the stained cells with 125 µL ethanol for 15 minutes at room 
temperature. The solubilized crystal violet was then transferred to a new 96-well plate and 
quantified by measuring absorbance at 550 nm on the SpectraMax plate reader. LB only wells 
were used as a blank. For statistical analysis, I performed a Welch’s two-sample t-test between 
the S and L strain to determine statistical significance between S biofilm formation and L biofilm 
formation.  
 
 Minimum inhibitory concentration assay 
 I also performed Minimum Inhibitory Concentration (MIC) experiments on both S and L 
strains to determine the relative resistance to different doses of antibiotics between the two 
strains. Ampicillin (500, 400, 200, 50 µg/ml), tetracycline (200, 100 and 10 µg/ml) and 
kanamycin (100, 50 and 10 µg/ml) were used in the MIC experiments. I started MIC cultures by 
inoculating 40 µL of overnight cultures of S and L into 4 mL of LB containing the above 
antibiotics, resulting in a starting cell density of ~107 cell/mL. Cultures were incubated at 37°C, 
200 rpm overnight. I qualitatively assessed growth through visual inspection of turbidity after 
~18 hours. The MIC experiment was set up in duplicate where each antibiotic concentration 
was represented twice per strain.  
 
Genome analysis for mutations in S strain  
 The genomes of the L and S strains were sequenced (Illumina) and alignments were 
generated prior to the start of this project (Gabe Fox and Ashley Frank, Lazzaro Lab). Candidate 
S strain mutation(s) potentially responsible for the small colony/low burden chronic infection 
phenotype were identified by comparing L and S strain genome sequences alignments in 
Geneious 10.2.3. Briefly, Illumina sequence reads were checked for quality with FastQC 
(Babraham Bioinformatics group) and adapters were trimmed using BBDuk. Reads from both S 
and L were aligned to the P. rettgeri reference genome in Geneious where single nucleotide 
polymorphisms (SNPs) were called using the software’s SNP algorithm. This genome sequence 
comparison revealed two potential differences leading to the S strain’s small colony/low 
burden infection phenotype. These are a CàT transition mutation in a penicillin binding protein 
(PBP) gene and a truncation in a lipoprotein gene. Of these, the PBP gene serves as my primary 
candidate for influencing the observed S phenotype due to its potential involvement in cell wall 
synthesis and antibiotic resistance, which is known to be a relevant phenotype for persisters.  
 
Rescue of S strain with wildtype PBP 
To confirm the candidate PBP mutation truly exists in the S strain and was not an artifact 
of Illumina sequencing, I amplified a 325 bp region of the PBP gene harboring the putative 
mutation in the S strain by PCR and verified the polymorphism with Sanger sequencing (Cornell 
Biotechnology Resource Center). I also performed parallel amplification and sequencing on the 
L strain to assure the mutation was unique to the S strain. The region was amplified with 
primers PBP_SNP_F: GTCACTTGGCCGCTTAAATC  and PBP_SNP_R: GGCCTATTACCGTCGAATCT. 
The 25 µl PCR reaction mixtures for this amplification consisted of 1x GoTaq buffer (Promega), 
200 µM deoxynucleotide triphosphates (dNTPs) (Promega), 0.2 µM F and R primers (Integrated 
DNA Technologies), 0.025 U/µl GoTaq Polymerase (Promega), 100 ng genomic DNA. I amplified 
DNA with the following thermalcycling conditions: 95°C for 2 min, followed by 30 cycles of 95°C 
for 30 sec, 52°C for 30 sec, 72°C for 30 sec, with a final extension at 72°C for 5 minutes. I 
verified the PCR product by running samples on a 1% agarose gel. The product was cleaned with 
the Qiaquick PCR Purification kit (Qiagen) and Sanger sequenced at Cornell’s Biotechnology 
Resource Center.  
 Once the mutation was confirmed by sequencing, I conducted PCR again to amplify the 
entire PBP gene (2,321 amplicon) from the L strain in order to get the desired wildtype product 
for a rescue study that involves expressing the Providencia rettgeri wildtype gene on a plasmid 
in the S strain mutant background (S-rescue). Due to the large size of the desired product, the 
PCR had to be optimized to increase yield and specificity. This was ultimately achieved through 
use of a high-fidelity polymerase, high GC polymerase buffer, elevation of annealing 
temperature (identified through gradient PCR), and use of DMSO. I amplified the entire gene 
with primers PBP_Full_F: AGACTTCAAAAGCAACCATATCT and PBP_Full_R: 
CACCTTCTAAAGCCCTTATATTGA.  50 µl PCR mixtures consisted of the following: 1x Phusion GC 
buffer (NEB), 200 µM dNTPs, 0.5 µM F and R primers, 3% DMSO, 0.02 U/µl Phusion Polymerase 
(NEB), 100 ng genomic DNA. DNA was amplified with the following thermalcycling conditions: 
98°C for 30 sec, followed by 30 cycles of 98°C for 10 sec, 59.3°C for 30 sec, 72°C for 2 min, with 
a final extension at 72°C for 5 minutes.   
Future experiments are planned to add adenines to the PBP gene amplicon for TA 
cloning into pCR2.1-TOPO (Invitrogen) and subcloning into the expression vector pBAD33mob 
(gift from Tobias Doerr, Cornell) through shared SalI and HindIII restriction sites.  The 
expression construct will then be transferred to the S strain via conjugation and used to express 
the WT PBP gene in the S strain background to determine if this gene can restore the wildtype 
phenotype (large colony, enhanced growth rate, increased host lethality and burden during in 
vivo infection).   
 
Results 
In vitro growth characterization of S and L 
I used both 96-well plate and flask-based cultures to compare the relative growth kinetics of 
the S and L strain during in vitro incubation. Both methods yielded the consistent result that the 
S strain grows more slowly and at a lower endpoint density than the wildtype strain (Figures 3 
and 4).  
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Figure 3 – In vitro growth curve performed in 96-well plate comparing S strain (small colony variant), L strain 
(wildtype) and a negative control of a blank (LB only). Bacterial OD was measured at a wavelength of 600 nm.  
Growth was measured for 24 hours. Lines represent average of 8 wells per strain.  
 
A)                                                                           B)  
    
Figure 4- Flask-based growth curve measurements using (A) optical density and (B) viable counts measured in 
colony forming units (CFU)/mL. Error bars account for variation between 3 replicates.  
  
Although the flask-based curve was not extended long enough to determine cell density 
during stationary phase, both the plate and flask curves indicate that L reaches a higher OD 
than S (L max plate OD = 0.51, S max plate OD = 0.27; L max flask OD = 2, S max flask OD = 1.75) 
and grows at a faster rate (L plate growth rate = 0.12 OD/hr, S plate growth rate = 0.08 OD/hr; L 
flask growth rate = 0.74 OD/hr, S flask growth rate = 0.47 OD/hr). The viable counts measured 
during the flask-based growth curve provide a more direct estimate of viable cell number (as 
OD is dependent on cell size, shape, and health), and support the results from both OD growth 
curves, demonstrating slower and lower growth by the S strain (L growth rate = 7.8x108 
CFU/mL/hr, S growth rate = 3.2x108 CFU/mL/hr) (Figure 2B). Additionally, I examined cells from 
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cultures of S and L under a compound microscope to assure that the difference in optical 
density was not merely due to a smaller physical cell size of S cells. Upon visualization at 1000x 
total magnification, no difference in cell size was observed (data not shown). Based on the data 
presented in Figures 1 & 2, my hypothesis that the S strain has slower growth compared to the 
L strain is supported.  
 
In vivo infections and survivorship curves for S vs L 
As an initial measurement of relative virulence during infection, I infected flies with 
either S or L strain via septic pinprick and monitored for fly survival (Figure 5A) and bacterial 
load (Figure 5B) over time. While both strains exhibit a bimodal infection where a percentage of 
flies are killed and the remaining survive with a chronic infection, the S strain appears to 
demonstrate less direct virulence (lower fly mortality and lower bacterial burden during chronic 
infection). The differences between the S and L infection start to be apparent around the 8 hour 
mark and solidify by the end of experiment when only 40% of the flies infected with L survive 
and harbor high bacterial loads (4.8 x104 cells/fly), whereas 85% of the flies infected with S 
survive with a lower bacterial load (1.7 x103 cells/fly).  
A)                                                                                                   
 
 
B)  
   
Figure 5– A) In vivo infections comparing bacterial load in Canton S. Drosophila melanogaster after infection with S 
or L strain of Providencia rettgeri. Bacterial load was measured and compared at 0, 4, 8, 24, and 48 hours post-
infection. Error bars indicate variance between 3 replicates. ***= statistical significance at a p-value <0.005. B) 
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Survivorship curve of Canton S. Drosophila melanogaster after infection with S strain, L strain or PBS (control). 
Assay started with 30 flies per treatment.  
 
While bacterial load stabilizes for both strains by 48 hours post-infection, the S strain is 
carried at a significantly lower load than the L strain (Figure 5A). Bacterial burden is statistically 
significantly different between infections with S and L strains at 8 hours, 24 hours and 48 hours 
post-infection. In addition, there is a drop in the bacterial load at the 8 hour post-infection mark 
for S strain (which occurred in all three replicates), which is not evident in the L strain.  
It is known that P. rettgeri infections activate the fly immune system via expression of 
antimicrobial peptides through the Imd pathway, even throughout chronic infection, and that 
the absence of a functional Imd pathway results in 100% host mortality during WT P. rettgeri 
infection (Myllymäki 2014). I therefore wanted to assess if disabling the fly’s Imd pathway 
would similarly allow for total (or increased) mortality during an S infection. To help determine 
whether the chronic infection of S is dependent on the host immune system, I repeated the in 
vivo infections using the Relish mutant of Drosophila melanogaster. Relish is an NF-kB 
transcription factor that controls expression of antimicrobial peptide genes of the Imd immune 
pathway. Flies that are mutant for the relish gene have diminished immune function (Ertürk-
Hasdemir 2009).  
 
 
 
 
 
A) 
  
B) 
  
Figure 6– A) In vivo infections comparing bacterial load in Relish Drosophila melanogaster after infection with S or 
L strain of Providencia rettgeri. Error bars indicate variance between 10-30 replicates. *= statistical significance at a 
p-value <0.05, ***=statistical significance at a p-value <0.005, ^= no statistical comparison could be made since 
Relish fruit flies infected with L strain did not survive past 72 hour timepoint. B) Survivorship curve monitoring 
survival of Relish Drosophila melanogaster after infection with S strain, L strain or PBS (control). 
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 In the absence of a fully functional host immune system, both strains are able to 
proliferate strongly for the first 24 hours (Figure 6A). After that point, all L-infected Relish flies 
die off and ultimately all die by 72 hours (Figure 6B), demonstrating higher mortality of the 
Relish flies (100% lethality) than wildtype flies (60% lethality) when infected with the L strain 
(Compare Figure 5B with Figure 6B). Similarly, the S-infection kills 40% more Relish flies than 
wildtype flies by 72 hours (compare Figure 5B with Figure 6B), with a continued lethal 
trajectory; however, the surviving S-infected Relish flies at 48 and 72 show a drop and leveling 
of bacterial load consistent with a chronic infection. Extended infection times and bacterial load 
sampling would be required to determine if the infection would persist indefinitely or 
ultimately cause 100% mortality. PBS control infections also led to higher death in Relish 
mutants than in wildtype controls (compare Figure 5B and 6B) suggesting that Relish flies are 
susceptible to death from injury due to lowered immune function.  
As previously explained, flies infected with P. rettgeri are either killed by the highly 
proliferating bacteria, or survive with a life-long chronic infection (see Figure 5) (Duneau 2017). 
I observed that infection with the S strain exhibits a similar bimodal infection outcome, 
however, the flies that survive do so with an even lower bacteria load than flies infected with 
the L strain (Figure 5A).  The low bacterial burden observed in the chronic S infection lead me to 
hypothesize that administration of a higher infectious dose of S would result in a more L-like 
infection phenotype (increased host lethality) in wildtype Canton S. Drosophila melanogaster. 
Before pursuing this, I first verified that use of increasing stock concentrations of S (OD1, OD2, 
OD5, OD10) for infection would result in a concomitant increase in T0 bacterial load. Results 
indicated that this method was reliable in transferring increasingly large amounts of bacteria to 
the fly, however, the percent increase was lower than expected for the percent increase in the 
cell stocks (data not shown). Although the increase in initial bacterial load was not exactly 
proportional to the increase in starting stock concentration, the general trend of increasing load 
with increasing cell stock concentration provided sufficient confidence to proceed with 
subsequent concentration-based experiments. We next performed the full experiment to 
monitor relative fly survival upon increasing infectious doses of the S strain (Figure 7). 
  
Figure 7. Survivorship curve monitoring survival of Canton S Drosophila melanogaster after infection with different 
concentrations of the S strain. S cell concentrations of OD 1,2,5, and 10 (corresponding to an initial does of ~3,000, 
6,000, 15,000, and 30,0000 cells, respectively) were prepared from the same overnight culture by diluting cells to 
OD1, and then pelleting and resuspending in smaller volumes of PBS to generated the more concentrated stocks. 
OD1 of the L strain was used as a control.  
 
When looking at the survivorship curve, as S strain dose increases, survivorship of fruit 
flies decreases. This is especially apparent 72 hours post-infection to 1 week post-infection (at 1 
week post-infection, S OD 1 survivorship = 85%, S OD 2 survivorship = 75%, S OD 5 survivorship 
= 65% and S OD 10 survivorship = 45%). As S strain inoculation dose increases, survivorship is 
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closer to L OD 1 survivorship (30% after 1 week). Based on the results, we can see that a higher 
infectious dose of the S strain does in fact lead to a more L-like infection phenotype with 
increased host lethality. This supports my initial hypothesis that since the S strain is more 
susceptible to the fly immune system, a higher concentrations of cells would be required in 
order to overwhelm the immune system and cause greater rates of fly lethality. A follow up 
experiment should be performed where bacterial load per fly is analyzed for higher S 
concentrations up to 72 hours post-infection (0, 4, 8, 24, 48 and 72 hours) to determine if 
higher S concentration infections leads to bacterial loads similar to L infection. 
 
In vitro Biofilm assay:  
Since biofilm formation is a common mechanism of persister cells, I evaluated the 
relative ability of S and L strains to form biofilms by an in vitro plate-based biofilm assay 
(O’Toole 2011). This assay stains the biofilm with crystal violet which is then solubilized in 
organic solvent for spectrophotometric measurement to quantify the intensity of the biofilm. I 
predicted that the S strain should be better at forming biofilms in comparison to the L strain if it 
is implicated in persistent infection within fruit flies.  
 Figure 8- In vitro biofilm assay comparing S strain and L strain’s ability to form a biofilm measuring crystal violet 
stained biofilm absorbance at 550 nm. Error bars indicate variance among 8 replicate wells. A control using only LB 
was performed and is accounted for in graph as a background where absorbance measurements from the control 
were subtracted from all L strain and S strain absorbance measurements. *= statistical significance at a p-value 
<0.05.  
 
Data indicates that the stained biofilm absorbance was higher for the L strain 
(OD=0.025) than the S strain (OD=0.0075) and the difference was statistically significant (p = 
0.05) (Figure 8).  This fails to support my hypothesis that biofilm formation would be higher in 
the S strain culture. Since overall intensity of crystal violet staining were relatively low, it is 
worth repeating the experiment to see if higher maximum concentrations of L and S strain can 
be achieved during growth in the microtiter plate.  Higher cell concentrations would allow for 
the bacteria to form biofilms more readily. This is because the larger the concentration, the 
more likely it is for bacteria, like Providencia rettgeri, to attach to a surface and communicate 
with other bacteria to do the same (Costerton, Stewart, & Greenberg, 1999).  Repeating this 
experiment in a minimal medium like M9 may also help to facilitate stronger biofilm formation 
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for more robust quantification and thus higher crystal violet staining during the biofilm assay. 
This is because in order for the bacterial cells to survive in a minimal media such as M9, it would 
be advantageous for bacteria to form biofilms as the biofilms will trap essential nutrients and 
water in the environment to promote bacterial growth (Costerton et al., 1999).   
 
Rescue of S strain with wildtype PBP:  
By comparing L and S strain genome sequences, we identified S strain mutation(s) 
potentially responsible for its small colony and low burden infection phenotypes. One of the 
identified mutations was a CàT transition mutation in the 3’ end of a PBP gene (Figure 9). This 
mutation was present in the Penicillin-binding protein’s C terminal region. Due to the PBPs 
involvement in cell wall synthesis and interactions with antibiotics, it was identified as the 
primary candidate for the S strain phenotype, and thus was selected for complementation by 
the wildtype gene. 
 
Figure 9- Genome comparison between L and S strain to identify the new mutation on the PBP gene in the S strain. 
The new mutation is circled.  
 
To verify that the PBP SNP was present in the S strain (and not an artifact of Illumina 
sequencing), a portion of the gene harboring the putative mutation was PCR amplified and run 
on a gel (Figure 10A). I confirmed the SNP mutation using Sanger sequencing of the 325 bp 
amplicon with comparison to an equivalent product from the wildtype strain. Next, I performed 
Penicillin-binding	 protein	1C
*2,176
0	bp 2,321
Penicillin-binding	 protein	1C
S	strain
gradient PCR using Phusion polymerase in order to optimize conditions for isolation of the 2.5 
kb wildtype PBP gene region from the L strain for the rescue study. Results from the gradient 
PCR suggest that the best annealing temperature for the PCR was 59.3 0C due to amount of 
pure product produced after running on an agarose gel (data not shown). I repeated PCR using 
this annealing temperature with the Phusion polymerase protocol to amplify sufficient product 
yield and specificity for use in the subsequent cloning project  (Figure 10B). In future efforts, the 
isolated gene will be cloned into pCR2.1-TOPO, subcloned into the expression vector pBADmob 
and transferred to the S strain via conjugation for expression of the WT PBP in the mutant PBP 
background.  Since the PBP is involved in cell wall synthesis, we predict that expression of the 
WT gene in the S background may restore colony size and infection phenotype (increased 
lethality).  
             A)                                                                               B)  
                                                    
Figure 10- a) Agarose gel of the 325 bp region around the  SNP of PBP gene from the S strain l. Wells, from left to 
right, are ladder, master mix with 1 ul of water (negative control) and PBP SNP S strain amplicon. b) Agarose gel of 
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the ~2.5-3 kb region encompassing the wildtype PBP gene. Wells, from left to right, are ladder, PBP gene product, 
replicate 1 and PBP gene product replicate 2.  
 
 
 
 
Minimum inhibitory concentration assay: 
Antibiotic resistance is a characteristic typically found in bacteria capable of persistent 
infection (Proctor, von Eiff, 2006). The S strain of P. rettgeri has a mutation in the penicillin-
binding protein (PBP) gene. PBPs are involved in cell wall formation and thus critical to the 
maintenance of cell integrity. This integrity can be disrupted when PBPs are bound by ß -lactam 
antibiotics (like ampicillin and penicillin), ultimately leading to the cell death (Williamson 1987). 
Mutations of the PBP may help reduce its affinity for antibiotics, and therefore I hypothesized 
that the S strain harboring the PBP mutation would have increased antibiotic resistance to 
ampicillin compared to the L strain.  I performed an MIC assay using ampicillin, kanamycin and 
tetracycline to determine antibiotic susceptibility differences between the L and S strain. 
Kanamycin and Tetracycline were used as controls as they both have different modes of action 
compared to ampicillin (kanamycin is an aminoglycoside antibiotic that targets the 30S 
ribosome while tetracycline is a protein synthesis inhibitor).  
 
 
 
 
 
 
Table 1 – Minimum Inhibitory Concentration (MIC) assay performed comparing growth between S strain and L 
strain when provided different concentrations of antibiotics. + =  growth - = no growth. 
 
Antibiotic & Concentration 
(µg/ml) 
S Strain L strain 
Ampicillin 500 - - 
Ampicillin 400 + + 
Ampicillin 200 + + 
Ampicillin 50 + + 
Kanamycin 100 - - 
Kanamycin 50 - - 
Kanamycin 10 + + 
Tetracycline 200 - - 
Tetracycline 100 + + 
Tetracycline 10 + + 
 
Both the S strain and L strain had the same MIC for kanamycin (50 µg/mL), tetracycline 
(200 µg/mL) and ampicillin (500 µg/mL) (Table 1). This opposes the hypothesis that the S strain 
would be more resistant to ampicillin (a ß-lactam) due to the mutation in its PBP. It should be 
noted that the ampicillin results for S and L strain were performed 4 times, as inconsistent 
results were obtained for the 500 µg/mL concentration, with S demonstrating resistance 
sometimes and susceptibility other times (resistance only occurred once (+) while susceptibility 
occurred twice (-).  
 
Discussion 
Small colony variants are implicated in many medically important infectious diseases 
that are capable of persistent infection. For example, patients suffering from cystic fibrosis tend 
to develop persistent infections with pathogenic strains of Pseudomonas aeruginosa (Tümmler 
1999). It has been noted that these bacteria that cause persistent infection do so due to their 
enhanced ability to produce biofilms, resist the effects of many antibiotics and grow slowly 
within their host (Santos and Hirshfield 2016). Thus, small colony variants need to be studied in 
order to improve available treatments for those suffering from persistent infections. In this 
study, I studied a small colony phenotype (S strain) for Providencia rettgeri, a pathogenic 
bacterial strain in Drosophila melanogaster, in order to determine whether it was a true small 
colony variant persister. This was done by first investigating whether the small colony mutation 
exhibited characteristics implicated in persistent infections (e.g slow growth, biofilm formation 
and increased antibiotic resistance) and then identifying potential genes that could account for 
persistent infection with the downstream intention of heterologously expressing the wildtype 
gene in the mutant background to determine if the wildtype phenotype is restored. 
In this study, I performed in vitro and in vivo growth curves in order to identify whether 
the S strain exhibited slow growth, a characteristic linked to persistent infection and small 
colony variants. All the in vitro growth assays (both plate and flask assays) support that the S 
strain grows more slowly and to a lower density than the L strain (Figures 3-4). This is also 
mimicked in the fly, where chronic infection is maintained with lower loads than L strain (Figure 
5). This slowed growth and maintenance of chronic infection is consistent with the persister 
phenotype; however additional experiments suggest the phenotype may be a simple growth 
defect and not related to canonical persistence. In previous work, it was found that slowed 
growth of persister staphylococcus is a necessary characteristic for small colony variants, 
observing that it is difficult for small colony variants to reach OD’s above 2 to 3 after 24 hours 
of incubation (von Eiff 1997). This is consistent with the results of our in vitro growth curves, 
where the S strain does not surpass an OD of 1.8. Other studies dealing with small colony 
variants also support the result that slow growth is a hallmark of persistent infection. For 
instance, it has been noted that small colony variants of staphylococcus grow at a slower rate in 
comparison to their wildtype counterparts and that this slow growth can be due to a variety of 
metabolic alterations including defects associated with the electron transport chain and the 
biosynthesis of metabolites (Proctor, von Eiff, 2006). The slowed in vivo proliferation of S 
relative to L is maintained in infection of Relish flies which have severely compromised immune 
systems (Figure 6). This means that regardless of immune function, the S strain will grow slower 
within the fly compared to the L strain. Since Relish flies do not have the capacity to clear 
themselves of infecting cells, the lower cell numbers of S truly represents a slower proliferation 
(and not enhanced clearance by the host). Based on the growth dynamics of the S strain of 
Providencia rettgeri, the S strain does exhibit slower growth, a characteristic implicated in small 
colony variants linked to persistent infection, however, it does not exhibit other characteristics 
of typical small colony variants, including enhanced biofilm formation and antibiotic resistance.  
 Due to its involvement in persistence, I compared biofilm formation between the L 
strain and S strain. Biofilm formation is a key virulence trait in many small colony variants and is 
heavily implicated in its ability to cause a persistent infection. This is because biofilms are 
relatively immobile, allow increased antibiotic resistance, and allow for exchange of beneficial 
genes between bacteria since they are closer together and adhere to nutrient rich surfaces 
within the host, which can allow the bacteria to persist within the host and resist innate host 
defenses (Costerton 1999). If the S strain were a true persister, it should produce more biofilm 
than the wildtype strain. Contrary to this prediction, biofilm intensity was lower in the S strain 
(Figure 8) suggesting that it may actually be less capable of forming a biofilm. It would be ideal 
to do a biofilm assay comparing the S strain and L strain ability to make biofilms in vivo to get a 
more realistic interpretation of biofilm status during host infection. However, this would be 
challenging due to interference of the host tissue and the technical requirements needed to 
isolate biofilms from the host. To expand upon the biofilm analysis, more replicates should be 
done in order to measure the reliability of the initial results. In addition, the biofilm assay 
should be performed again using an increased incubation time in order to determine if it takes 
longer for the S strain to form a biofilm that exceeds that of the L strain.   
Studies have shown that small colony variant persisters can tolerate higher 
concentrations of antibiotics compared to wildtype cells (Proctor, Kriegeskorte, 2014). Due to a 
mutation in the PBP gene of the S strain (Figure 9), I predicted that antibiotic resistance would 
only be greater for ß-lactam antibiotics (like ampicillin) in the S strain and that kanamycin and 
tetracycline susceptibility would be the same. However, in the MIC assay, I found that S strain 
and L strain had the same susceptibility to all three antibiotics and both strains were equally 
resistant to ampicillin (MIC of 500 µg/mL, Table 1). This also disproves the hypothesis that S 
strain would have increased antibiotic resistance to ampicillin if it is a true small colony variant 
persister. However, this result is not surprising since the S strain also does not have an 
enhanced ability to form biofilms (Figure 8), which can be responsible for the increased 
antibiotic resistance of canonical small colony variants. Although biofilm formation and 
antibiotic tolerance can be independent traits, the lack of both of these features in the S strain 
lends support against its capacity to act as small colony variant persister. However, the tests 
that were performed (for both biofilm and MIC) were done outside of the fly and do not 
provide insight into the physiologies that would occur during an in vivo infection. It is therefore 
suggested to test ampicillin resistance during infection in the host. If the S strain demonstrates 
a higher tolerance of ampicillin during chronic infection than the L strain, then it may still be a 
candidate for a canonical persister cell.  
In the initial stages of this study, candidate genes were identified that could potentially 
contribute to the S strain phenotype (small colony and slow growth). Upon genome 
comparisons between the S and L strains, two particular mutations were marked as high-
priority candidates for investigation. These were mutations in the penicillin binding protein 
gene and a lipoprotein gene. Both genes are predicted to be important to pathogenicity since 
PBP is an important marker for antibiotic binding and lipoprotein is a membrane protein that 
serves as a recognizable antigen for the immune system of the host. Due to the PBPs 
involvement in antibiotic binding as well as its necessity for cell wall synthesis, it served as our 
primary candidate for further experimentation. While we have begun the molecular biology to 
clone the wildtype PBP gene into an expression vector, our ultimate goal is to express this 
wildtype gene on a pBAD vector (Guzman 1995) in the mutant background to determine if the 
wildtype phenotypes are restored (large colony, faster growth, higher fly lethality etc.) This will 
therefore demonstrate whether the mutation found in the PBP gene is an influential gene in 
the observed S phenotype. Expanding upon the rescue study described above, if that fails, a 
rescue study can be done using the lipoprotein gene instead of the PBP gene (mentioned in 
methods, p. 6) in order to see whether the lipoprotein gene is an influential gene in the 
observed S phenotype.   
Conclusion 
Based on the results accumulated in this study, I concluded that the S strain of 
Providencia rettgeri is not likely a canonical small colony variant with persistence in the 
Drosophila melanogaster host. This is because it does not have certain characteristics (biofilm 
formation, enhanced antibiotic tolerance) that would match its ability to persist within its host, 
Drosophila melanogaster. The S strain exhibited slow growth and decreased pathogenicity and 
was able to retain a persistent infection within its host; however, the S strain was not able to 
form biofilms as effectively as the wild type L strain and consequently had identical antibiotic 
resistance to the L strain. Since these are two features that are significant in most medically 
important small colony variants involved in persistent infection, I concluded that the S strain 
(small colony phenotype) of Providencia rettgeri is most likely not a suitable model strain for 
studying small colony variants and their implication in persistent infections. However, we 
believe this strain’s interesting physiology (small colony and retained persistence in the host) is 
worthy of continued study as it may reveal novel insight into bacterial growth dynamics inside 
and outside of the host.  
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